|
Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Quebec City, Canada, June 16-21, 2007.
Robert E. Booth, PhD (University of Colorado, RM Node).
This presentation, part of a symposium at the CPDD meeting entitled, "Primary Findings from HIV/AIDS Research in the NIDA Clinical Trials Network" (chaired by Donald A. Calsyn), describes protocol CTN-0017, "HIV and HCV Intervention in Drug Treatment Settings." This study aimed to reduce injection-related HIV and HCV risk behaviors, while also increasing treatment entry and retention. Three interventions were compared: NIDA Counseling & Education Intervention (C&E), which offers HIV & HCV education and protective skills training and encouragement; Therapeutic Alliance Intervention (TA), which uses a single session with an outpatient counselor to identify treatment goals, tasks, and expectations; and Treatment as Usual (TAU), which includes typical clinic procedures such as risk reduction education and referral for HIV testing and continuing care. The presentation ends with an analysis of the "outcomes so far." (Presentation, PowerPoint slides, English, 2007)
 Keywords: HIV/AIDS | Hepatitis C | Injection drug use | Sexual risk behavior | Sexually transmitted diseases | Therapeutic alliance | College on Problems of Drug Dependence (CPDD) annual meeting 2007
Document No: 205
Submitted by Robert E. Booth, PhD, Lead Investigator (7/2007). |
